Literature DB >> 1657426

Production of protein-associated DNA breaks by 8-methoxycaffeine, caffeine and 8-chlorocaffeine in isolated nuclei from L1210 cells: comparison with those produced by topoisomerase II inhibitors.

P Russo1, L Poggi, S Parodi, A M Pedrini, K W Kohn, Y Pommier.   

Abstract

8-Methoxycaffeine (8-MOC) is a caffeine derivative, more potent than the parent compound, but very similar to caffeine in terms of induction of DNA single-strand breaks (SSBs), DNA double-strand breaks (DSBs) and DNA-protein crosslinks (DPCs). We have studied the capability of 8-MOC, caffeine and 8-chlorocaffeine (8-CC) of inducing SSBs, DSBs and DPCs, and we have compared 8-MOC with ellipticine, a typical inhibitor of DNA topoisomerase II. The DNA effects of 8-MOC appeared similar to those of ellipticine. In both cases SSBs, DSBs and DPCs were present in a similar ratio, and they were rapidly reversible after removal of the drug. The dose-response curve was bell-shaped for both compounds. In addition, 8-MOC, caffeine and 8-CC were capable of inhibiting DSBs induced by ellipticine. These results were obtained at the level of L1210 cell nuclei. In spite of these functional similarities, 8-MOC, caffeine and 8-CC were unable to stimulate the formation of a cleavable complex by purified L1210 topoisomerase II (p170 form) when SV40 DNA and human c-myc DNA were used as substrate. These methylated oxypurines could be active on a different form of topoisomerase II, or, alternatively, they could be active only in the natural chromatin 'milieu' within the nucleus.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1657426     DOI: 10.1093/carcin/12.10.1781

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  4 in total

1.  "Atypical" multidrug resistance in human ovarian cancer cell line A2780 selected for resistance to doxorubicin (A2780 DX3).

Authors:  G Cimoli; M Valenti; E Noviello; S Parodi; A Mazzoni; E Rovini; F De Sessa; P Russo
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

2.  Selective cytotoxicity of pancratistatin-related natural Amaryllidaceae alkaloids: evaluation of the activity of two new compounds.

Authors:  Carly Griffin; Jerald Nair; James McNulty; Siyaram Pandey; Natasha Sharda; Divya Sood
Journal:  Cancer Cell Int       Date:  2007-06-05       Impact factor: 5.722

3.  Circumvention of atypical multidrug resistance with tumor necrosis factor.

Authors:  G Cimoli; M Valenti; S Parodi; F De Sessa; P Russo
Journal:  Jpn J Cancer Res       Date:  1994-02

4.  Potentiation of topoisomerase I and II inhibitors cell killing by tumor necrosis factor: relationship to DNA strand breakage formation.

Authors:  G Orengo; E Noviello; G Cimoli; G Pagnan; S Parodi; M Venturini; P Conte; F Schenone; G Conzi; P Russo
Journal:  Jpn J Cancer Res       Date:  1992-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.